FR3654M - β(-3:5 diiodo-4 hydroxyphényl) βhydroxy αméthyl n méthyléthylamine-synthese et a titre d'hypertenseur a action prolongée, son utilisation dans le traitement des collapsus cardiovasculaires. - Google Patents

β(-3:5 diiodo-4 hydroxyphényl) βhydroxy αméthyl n méthyléthylamine-synthese et a titre d'hypertenseur a action prolongée, son utilisation dans le traitement des collapsus cardiovasculaires.

Info

Publication number
FR3654M
FR3654M FR953054A FR953054A FR3654M FR 3654 M FR3654 M FR 3654M FR 953054 A FR953054 A FR 953054A FR 953054 A FR953054 A FR 953054A FR 3654 M FR3654 M FR 3654M
Authority
FR
France
Prior art keywords
βhydroxy
αmethyl
methylethylamine
diiodo
hydroxyphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR953054A
Other languages
English (en)
Inventor
Henri Tron-Loisel
Roger Truchot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR953054A priority Critical patent/FR3654M/fr
Priority to FR992952A priority patent/FR3812M/fr
Priority to CH1428164A priority patent/CH423812A/fr
Priority to GB44535/64A priority patent/GB1040736A/en
Priority to BE655198D priority patent/BE655198A/xx
Priority to DEM63013A priority patent/DE1273538B/de
Application granted granted Critical
Publication of FR3654M publication Critical patent/FR3654M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
    • C07C215/58—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C07C215/60—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR953054A 1963-11-08 1963-11-08 β(-3:5 diiodo-4 hydroxyphényl) βhydroxy αméthyl n méthyléthylamine-synthese et a titre d'hypertenseur a action prolongée, son utilisation dans le traitement des collapsus cardiovasculaires. Expired FR3654M (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR953054A FR3654M (fr) 1963-11-08 1963-11-08 β(-3:5 diiodo-4 hydroxyphényl) βhydroxy αméthyl n méthyléthylamine-synthese et a titre d'hypertenseur a action prolongée, son utilisation dans le traitement des collapsus cardiovasculaires.
FR992952A FR3812M (fr) 1963-11-08 1964-10-28 Nouveau médicament hypertenseur, utilisable dans le traitement des collapsus cardiovasculaires, a base de 1-(4-hydroxy-3,5-diiodo-phényl)-2-amino-propanol.
CH1428164A CH423812A (fr) 1963-11-08 1964-11-02 Procédé de préparation de nouveaux dérivés de la phénylpropanolamine
GB44535/64A GB1040736A (en) 1963-11-08 1964-11-02 New derivatives of phenylpropanolamine, their process of preparation and therapeutic composition containing said derivatives
BE655198D BE655198A (fr) 1963-11-08 1964-11-03
DEM63013A DE1273538B (de) 1963-11-08 1964-11-05 Verfahren zur Herstellung jodierter Phenylpropanolamine und deren Saeureadditionssalze

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR953054A FR3654M (fr) 1963-11-08 1963-11-08 β(-3:5 diiodo-4 hydroxyphényl) βhydroxy αméthyl n méthyléthylamine-synthese et a titre d'hypertenseur a action prolongée, son utilisation dans le traitement des collapsus cardiovasculaires.
FR992952A FR3812M (fr) 1963-11-08 1964-10-28 Nouveau médicament hypertenseur, utilisable dans le traitement des collapsus cardiovasculaires, a base de 1-(4-hydroxy-3,5-diiodo-phényl)-2-amino-propanol.

Publications (1)

Publication Number Publication Date
FR3654M true FR3654M (fr) 1965-11-02

Family

ID=26204232

Family Applications (2)

Application Number Title Priority Date Filing Date
FR953054A Expired FR3654M (fr) 1963-11-08 1963-11-08 β(-3:5 diiodo-4 hydroxyphényl) βhydroxy αméthyl n méthyléthylamine-synthese et a titre d'hypertenseur a action prolongée, son utilisation dans le traitement des collapsus cardiovasculaires.
FR992952A Expired FR3812M (fr) 1963-11-08 1964-10-28 Nouveau médicament hypertenseur, utilisable dans le traitement des collapsus cardiovasculaires, a base de 1-(4-hydroxy-3,5-diiodo-phényl)-2-amino-propanol.

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR992952A Expired FR3812M (fr) 1963-11-08 1964-10-28 Nouveau médicament hypertenseur, utilisable dans le traitement des collapsus cardiovasculaires, a base de 1-(4-hydroxy-3,5-diiodo-phényl)-2-amino-propanol.

Country Status (5)

Country Link
BE (1) BE655198A (fr)
CH (1) CH423812A (fr)
DE (1) DE1273538B (fr)
FR (2) FR3654M (fr)
GB (1) GB1040736A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6087M (fr) * 1967-01-10 1968-06-04

Also Published As

Publication number Publication date
CH423812A (fr) 1966-11-15
DE1273538B (de) 1968-07-25
BE655198A (fr) 1965-03-01
GB1040736A (en) 1966-09-01
FR3812M (fr) 1966-01-03

Similar Documents

Publication Publication Date Title
FR3654M (fr) β(-3:5 diiodo-4 hydroxyphényl) βhydroxy αméthyl n méthyléthylamine-synthese et a titre d'hypertenseur a action prolongée, son utilisation dans le traitement des collapsus cardiovasculaires.
FR2495M (fr) (alcényle-2)-17α-δ<1><3><5> <(10)> oestratriénediols-3,17β et leurs esters.
FR1438M (fr) Nouveau médicament efficace dans le traitement de l'athérosclérose.
FR3395M (fr) Nouveau médicament notamment pour le traitement des états neurodépressifs et des psychoses d'anxiété.
CH426087A (de) Hochvoluminöses, elastisches Garn und Verfahren zu seiner Herstellung
FR3534M (fr) Nouvelle isoquinoléine utilisable en thérapeutique, notamment comme agent antitussif.
FR2692M (fr) Nouveaux a-nor-b-homo-stéroides utilisables en thérapeutique, notamment comme agents anti-inflammatoires.
FR151M (fr) Nouveau médicament notamment pour le traitement des états neuro-dépressifs et des psychoses d'anxiété.
FR2596M (fr) Nouvelles compositions thérapeutiques, en particulier pour le traitement de l'angine de poitrine.
FR342M (fr) Nouveau médicament stéroide tri-hydroxylé notamment pour le traitement des spasmes d'origine coronaire.
FR3308M (fr) Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents anti-inflammatoires.
FR3843M (fr) Nouvelles bases azotées a propriétés antispasmodique et vasodilatatrice.
FR2338M (fr) Nouveaux remedes destinés notamment au traitement des céphalées d'origine vasculaire.
FR3419M (fr) Nouveaux médicaments notamment pour le traitement des états neuro-dépressifs et des psychoses d'anxiété.
FR2413M (fr) Nouveau médicament notamment pour le traitement des manifestations inflammatoires et douloureuses.
DK108381C (da) Høsprede- og vendemaskine.
FR1867M (fr) Composition nouvelle destinée notamment au traitement de la cholestérolémie.
FR1401474A (fr) Enzyme protéolytique, et procédés pour sa préparation et pour son utilisation
FR3126M (fr) Nouveau médicament notamment pour le traitement des états neuro-dépressifs et des psychoses d'anxiété.
FR3268M (fr) Nouveau médicament notamment pour le traitement des états neurodépressifs et des psychoses d'anxiété.
FR3062M (fr) Nouveau médicament notamment pour le traitement des états neurodépressifs et des psychoses d'anxiété.
FR2885M (fr) Nouveau médicament, notamment pour le traitement des états neuro-dépressifs et des psychoses d'anxiété.
FR3315M (fr) Nouveau médicament notamment pour le traitement des états neurodépressifs et des psychoses d'anxiété.
FR3096M (fr) Nouveau médicament notamment pour le traitement des états d'adynamie.
FR3199M (fr) Solutés stables et atoxiques de peroxydes, notamment pour le traitement du cancer.